
Dihexa· 375mg
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Vendor VerdictScore
Our Rating — VialVerdict's internal supplier score until more customer reviews are available.
Product + vendor context
Dihexa from Royal
This page covers Dihexa as sold by Royal. Product-specific reviews are only counted when a reviewer selects this exact vendor/product pair. Vendor reviews, external review signals, and the vendor VerdictScore are shown separately so broad vendor reputation does not masquerade as product-specific proof.
Dihexa is a synthetic peptide-like compound researched for its interaction with the hepatocyte growth factor (HGF) pathway. Most buyer interest comes from nootropic and cognitive-enhancement communities looking for synapse formation, memory, focus, and neuroplasticity signals.
Current catalogue snapshot: 375mg vial, $125.00 total, $0.33/mg, listed in stock. VialVerdict records 99.0% purity for this row.
Frequently asked questions about Royal Dihexa
Is Royal Dihexa reviewed separately from vendor reviews?
What does VialVerdict know about this Dihexa listing?
Why show vendor reviews on a Dihexa product page?
Does VialVerdict earn from Royal links?
Vendor-level reviews for Royal
These reviews describe the vendor overall — shipping, packaging, support, and fulfilment — not necessarily this exact Dihexa listing.
Other vendors selling Dihexa
Ranked by rating, price, and listed product data.
Evidence-led research
Verify the evidence behind this Dihexa listing
NAD+ listing checklist
A plain-language NAD+ LISTING CHECK for comparing NAD+ vendor pages by vial size, price per mg, lot-matched COA/HPLC proof, shipping, reviews, and claim risk.
Read the guideBPC-157 listing checklist
A plain-language BPC-157 LISTING CHECK for comparing vendor pages by exact product form, lot-matched COA/HPLC proof, price per mg, shipping, reviews, and claim risk.
Read the guide